Release Date: 17/08/16 08:28 Summary: GMM Completion and Compulsory Acquisition,GMM-GXY.AX Price Sensitive: Yes Download Document 788.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%